Quinta-Analytica s.r.o.

Prague 44 trials 1 recruiting

44 Registered trials

1 Currently recruiting

Organisation

Quinta-Analytica s.r.o.

Location

Prague, Czechia

Identifier

ORG-100011570

Address

Umelecka 305/1, Moravska Ostrava, 702 00, Czechia

Departments

Clinic
clinical
Clinical Unit
Clinical Unit of Quinta-Analytica s.r.o
Klinika onkologie a radioterapie
management
N/A
Quinta-Analytica

Clinical trials at this site (44)

Search interface

Randomized, open-label, single-dose, two-period, cross-over, bioequivalence study comparing Linagliptin 5 mg film-coated tablets (Vipharm S.… Ended

2024-514678-35-00 Bioequivalence study in healthy volunteers under fastin 2 2024-11-15
An open label, randomized, crossover, two-period, two-sequence, multiple dose study to assess the relative bioavailability of Rotigotine 4.5… Ended

2024-515841-41-00 Not applicable (submitted trial is a bioavailability st 2 2024-11-04
Open-label, randomized, two-treatment, two-period, two-sequence, cross-over, single dose, bioequivalence study comparing ISOPRINOSINE® FORTE… Ended

2024-514146-37-00 not applicable (submitted trial is a bioequivalence stu 2 2024-10-24
An open label, randomized, single dose, two-sequence, two-treatment, four-period, fully replicate, cross-over pharmacokinetic study comparin… Ended

2024-516942-21-00 Not applicable (submitted trial is a bioavailability st 2 2024-10-21
An open label, randomized, two-period, two-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Val… Ended

2024-516184-87-00 not applicable (submitted trial is a bioavailability st 2 2024-10-18
An open label, randomized, crossover, two-period, two-sequence, single dose study to assess the relative bioavailability of Rotigotine 4.5 m… Ended

2024-515840-21-00 Not applicable (submitted trial is a bioavailability st 2 2024-09-30
Ibuprofen 200 mg bioequivalence study Ended

2024-516161-36-00 not applicable (submitted trial is BE) 2 2024-09-13
A Randomized, Single-dose, Crossover, Two-period, Pilot Comparative Bioavailability Study of Alendronate 70 mg effervescent vs. Fosamax 70 m… Ended

2024-513615-26-00 not applicable (submitted trial is a comparative bioava 2 2024-09-12
Randomized, open-label, single dose, two-period, two-treatment, cross-over bioequivalence study comparing test product Rivaroxaban/Acetylsal… Ended

2024-513665-40-00 not applicable (submitted trial is a bioequivalence in 2 2024-06-25
An open label, randomized, two-period, two-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Val… Ended

2024-511570-77-00 not applicable (submitted trial is a bioavailability st 2 2024-05-13
Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects Ended

2023-506633-30-00 N/A submitted trial is conducted on healthy subjects 3 2023-10-13
Randomized, open-label, single dose, three-period, three treatment cross-over bioavailability study comparing test products Rosuvastatin/Eze… Ended

2023-507048-35-00 not applicable (submitted trial is bioavailability stud 3 2023-10-11
Randomized, Open-label, Single-Dose, Two-treatment, Two-period, Cross-over, Pivotal Bioequivalence Study Comparing Amoxicilin/Clavulanic aci… Ended

2023-503233-22-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-09-27
An open label, randomized, three-period, three-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of… Ended

2023-504760-42-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-09-27
Randomized, open-label, single dose, four-period, cross-over drug-drug interaction study comparing reference products Crestor 20 mg film coa… Ended

2023-505153-41-00 Not applicable (submitted trial is a study in healthy s 3 2023-08-17
Single Dose Crossover Comparative Bioavailability and Food Effect Study of Celecoxib 10 mg/1 mL Oral Suspension versus Celebrex®️ (celecoxib… Ended

2023-504052-99-00 Musculoskeletal and connective tissue disorders, Dysmen 2 2023-07-31
A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women. Ended

2023-503948-13-00 Healthy Post-menopausal women. 3 2023-07-20
Randomized, open-label, single dose, two-period, cross-over bioequivalence study comparing test formulation Rosuvastatin/Amlodipine/Ramipril… Ended

2023-503822-38-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-06-19
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P… Ended

2023-504132-18-00 N.A. (submitted trial is a bioequivalence study in heal 2 2023-06-19
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P… Ended

2023-503345-59-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-05-23